PTC Therapeutics PTCT Business Segments — Manufacturing Costs
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ManufacturingCosts.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's business segments — manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's business segments — manufacturing costs?
- PTC Therapeutics (PTCT) reported business segments — manufacturing costs of $9.09M in Q1 2026.
- How has PTC Therapeutics's business segments — manufacturing costs changed year-over-year?
- PTC Therapeutics's business segments — manufacturing costs decreased by 39.2% year-over-year, from $14.95M to $9.09M.
- What is the long-term trend for PTC Therapeutics's business segments — manufacturing costs?
- Over 3 years (2022 to 2025), PTC Therapeutics's business segments — manufacturing costs has grown at a -14.6% compound annual growth rate (CAGR), from $108.03M to $67.32M.
- What does business segments — manufacturing costs mean?
- This encompasses the operational expenses incurred in the production, quality control, and supply chain management of pharmaceutical products. Monitoring this metric helps assess the scalability and cost-efficiency of the company's manufacturing processes.